Zomedica Continues To Expect FY24 Revenue Of $31M-$35M, Est $34.1M
Portfolio Pulse from Benzinga Newsdesk
Zomedica projects its FY24 revenue to be between $31M-$35M, aligning with an estimated $34.1M. This forecast suggests a growth of about 39% from its FY23 revenue of $25.2M.
May 09, 2024 | 9:42 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Zomedica expects FY24 revenue to range between $31M-$35M, indicating a significant growth from FY23's $25.2M.
The positive revenue forecast for FY24 suggests a strong growth trajectory for Zomedica, likely leading to increased investor confidence and potentially a rise in stock price in the short term.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100